Stemcell-derivedβ (SC-β)cellscould provide unlimited human βcellstoward a curative diabetes treatment. Differentiation of SC-βcellsyields transplantable islets that secrete insulin inresponsetoglucosechallenges. Following transplantation ...
Humanstemcell-derivedβ (SC-β)cellsstill exhibit limitedglucoseresponserequired for insulin secretion due to glycolytic bottlenecks, yet how these metabolic abnormalities impactglucose...
Stemcell-derivedβ (SC-β)cellscould provide unlimited human βcellstoward a curative diabetes treatment. Differentiation of SC-βcellsyields transplantable islets that secrete insulin inresponsetoglucosechallenges. Following transplantation into mice, SC-βcellfunction is comparable to human islets, but the magnitude and consistency ofresponsein vitro are less robust than ...
The GSISresponsein cadaveric islets was five times higher than that observed instemcell-derivedbetacells[153]. achieved by the timely addition of small molecules and growth factors in a ...
Glucose-stimulated insulin secretion is deficient instemcell-derivedβ (SC-β)cellsin vitro. Davis et al. use metabolomic analysis to define a glycolytic bottleneck inhibitingglucosemetabolism and sensing in SC-βcells.Cell-permeable intermediates bypass this bottleneck, as does transplantation in vivo, producing insulin secretion indistinguishable from human islets.
Furthermore, visual representations like the one above help us fully grasp the concept of Stem Cell Derived Glucose Response.
Lin et al. reviewglucosemetabolic defects instemcell-derivedβcellsand how these pathways regulate their maturation, offering insights into targetingglucosemetabolism to improve the safety and efficacy ofstemcell-derivedβcellsfor diabetes treatment.
Clinical studies on the treatment of type 1 diabetes with device-encapsulated pancreatic precursorcellsderivedfrom human embryonicstemcellsfound that insulin output was insufficient for ...
In cocultures of astrocytes and neuronsderivedfrom AD subjects, deficient astrocyte lactate production and transfer to neurons was corrected by IDO1 inhibition, resulting in improved neuronalglucosemetabolism.
